Steven Cohen Natera, Inc. Transaction History

Point72 Asset Management, L.P.

$44.6 Billion
Q2 2025

A detailed history of Steven Cohen (Point72 Asset Management, L.P.) transactions in Natera, Inc. stock. As of the latest transaction made, Point72 Asset Management, L.P. holds 234,996 shares of NTRA stock, worth $39.3 Million. This represents 0.09% of its overall portfolio holdings.

Number of Shares

234,996

Previous 624,777 62.39%

Holding current value

$39.3 Million

Previous $88.3 Million 55.06%

% of portfolio

0.09%

Previous 0.22%

27 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Aug 14, 2025	SELL	$132.23 - $171.87 $51.5 Million - $67 Million	-389,781 Reduced 62.39%	234,996 $39.7 Million
Q1 2025 May 15, 2025	BUY	$132.63 - $177.0 $42.4 Million - $56.6 Million	319,534 Added 104.68%	624,777 $88.3 Million
Q4 2024 Feb 14, 2025	SELL	$117.67 - $174.0 $46.1 Million - $68.2 Million	-391,799 Reduced 56.21%	305,243 $48.3 Million
Q3 2024 Nov 14, 2024	BUY	$97.75 - $129.67 $13.2 Million - $17.5 Million	135,103 Added 24.04%	697,042 $88.6 Million
Q2 2024 Aug 14, 2024	BUY	$85.28 - $112.6 $25.4 Million - $33.6 Million	298,193 Added 113.06%	561,939 $60.9 Million
Q1 2024 May 15, 2024	BUY	$59.21 - $92.9 $15.2 Million - $23.9 Million	256,826 Added 3711.36%	263,746 $24.1 Million
Q4 2023 Feb 14, 2024	BUY	$37.55 - $62.64 $74,949 - $125,029	1,996 Added 40.54%	6,920 $433,000
Q3 2023 Nov 14, 2023	BUY	$43.4 - $62.52 $213,701 - $307,848	4,924 New	4,924 $217,000
Q1 2023 May 15, 2023	SELL	$36.57 - $58.29 $3.39 Million - $5.41 Million	-92,778 Reduced 94.75%	5,143 $285,000
Q4 2022 Feb 14, 2023	BUY	$34.17 - $47.91 $577,028 - $809,056	16,887 Added 20.84%	97,921 $3.93 Million
Q3 2022 Nov 14, 2022	BUY	$36.93 - $56.68 $2.99 Million - $4.59 Million	81,034 New	81,034 $3.55 Million
Q2 2022 Aug 15, 2022	SELL	$28.13 - $44.54 $2.27 Million - $3.59 Million	-80,600 Closed	0 $0
Q1 2022 May 16, 2022	SELL	$30.32 - $91.33 $29.7 Million - $89.5 Million	-979,782 Reduced 92.4%	80,600 $3.28 Million
Q4 2021 Feb 14, 2022	BUY	$86.26 - $119.0 $265,939 - $366,877	3,083 Added 0.29%	1,060,382 $99 Million
Q3 2021 Nov 15, 2021	BUY	$100.17 - $126.36 $56.5 Million - $71.3 Million	564,045 Added 114.35%	1,057,299 $118 Million
Q2 2021 Aug 16, 2021	SELL	$86.05 - $119.72 $21 Million - $29.3 Million	-244,428 Reduced 33.13%	493,254 $56 Million
Q1 2021 May 17, 2021	BUY	$91.47 - $124.36 $64.1 Million - $87.1 Million	700,432 Added 1880.35%	737,682 $74.9 Million
Q4 2020 Feb 16, 2021	SELL	$66.66 - $111.74 $82.1 Million - $138 Million	-1,230,883 Reduced 97.06%	37,250 $3.71 Million
Q3 2020 Nov 16, 2020	BUY	$45.89 - $72.67 $16.5 Million - $26.1 Million	359,181 Added 39.52%	1,268,133 $91.6 Million
Q2 2020 Aug 14, 2020	BUY	$26.36 - $49.86 $18.7 Million - $35.5 Million	711,231 Added 359.71%	908,952 $45.3 Million
Q1 2020 May 15, 2020	BUY	$17.27 - $40.17 $3.16 Million - $7.36 Million	183,221 Added 1263.59%	197,721 $5.9 Million
Q4 2019 Feb 14, 2020	BUY	$32.1 - $40.4 $465,450 - $585,800	14,500 New	14,500 $489,000
Q3 2019 Nov 15, 2019	SELL	$25.38 - $34.89 $462,448 - $635,730	-18,221 Closed	0 $0
Q2 2019 Aug 14, 2019	SELL	$17.75 - $27.58 $815,062 - $1.27 Million	-45,919 Reduced 71.59%	18,221 $503,000
Q1 2019 May 15, 2019	SELL	$11.34 - $20.62 $5.15 Million - $9.37 Million	-454,289 Reduced 87.63%	64,140 $1.32 Million
Q4 2018 Feb 14, 2019	SELL	$12.32 - $24.38 $13.5 Million - $26.8 Million	-1,098,441 Reduced 67.94%	518,429 $7.24 Million
Q3 2018 Nov 14, 2018	BUY	$18.82 - $28.96 $30.4 Million - $46.8 Million	1,616,870 New	1,616,870 $38.7 Million

Others Institutions Holding NTRA

# of Institutions

707

Shares Held

125M

Call Options Held

590K

Put Options Held

260K

View Full List

About Natera, Inc.

Ticker NTRA
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 96,957,400
Market Cap $16.2B
Description
Natera, Inc., a diagnostics company, develops and commercializes molecular testing services worldwide. It offers Panorama, a non-invasive prenatal test that screens for chromosomal abnormalities of a fetus with a blood draw from the mother, as well as twin pregnancies for zygosity; Vistara, a single-gene mutations screening test to identify sing...

More about NTRA

Track Steven Cohen's Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Point72 Asset Management, L.P., based on Form 13F filings with the SEC.

News

Stay updated on Point72 Asset Management, L.P. and Steven Cohen with notifications on news.

Account